Collectively, these results show that EGFR signaling activates PPP through 6PGD to enhance the radiation resistance of tumor cells and provide molecular basis to overcome GBM radioresistance by inhibiting 6PGD phosphorylation. The gene discussed is EGFR; the disease is glioblastoma.